Related Experiment Video
Updated: Oct 22, 2025

In situ Subcellular Fractionation of Adherent and Non-adherent Mammalian Cells
Published on: July 23, 2010
The Mus musculus Papillomavirus Type 1 E7 Protein Binds to the Retinoblastoma Tumor Suppressor: Implications for
Tao Wei1, Miranda Grace2, Aayushi Uberoi1
1McArdle Laboratory for Cancer Research, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.
Abstract:
The species specificity of papillomaviruses has been a significant roadblock for performing in vivo pathogenesis studies in common model organisms. The Mus musculus papillomavirus type 1 (MmuPV1) causes cutaneous papillomas that can progress to squamous cell carcinomas in laboratory mice. The papillomavirus E6 and E7 genes encode proteins that establish and maintain a cellular milieu that allows for viral genome synthesis and viral progeny synthesis in growth-arrested, terminally differentiated keratinocytes. The E6 and E7 proteins provide this activity by binding to and functionally reprogramming key cellular regulatory proteins. The MmuPV1 E7 protein lacks the canonical LXCXE motif that mediates the binding of multiple viral oncoproteins to the cellular retinoblastoma tumor suppressor protein, RB1. Our proteomic experiments, however, revealed that MmuPV1 E7 still interacts with RB1. We show that MmuPV1 E7 interacts through its C terminus with the C-terminal domain of RB1. Binding of MmuPV1 E7 to RB1 did not cause significant activation of E2F-regulated cellular genes. MmuPV1 E7 expression was shown to be essential for papilloma formation. Experimental infection of mice with MmuPV1 expressing an E7 mutant that is defective for binding to RB1 caused delayed onset, lower incidence, and smaller sizes of papillomas. Our results demonstrate that the MmuPV1 E7 gene is essential and that targeting noncanonical activities of RB1, which are independent of RB1's ability to modulate the expression of E2F-regulated genes, contribute to papillomavirus-mediated pathogenesis. IMPORTANCE Papillomavirus infections cause a variety of epithelial hyperplastic lesions, or warts. While most warts are benign, some papillomaviruses cause lesions that can progress to squamous cell carcinomas, and approximately 5% of all human cancers are caused by human papillomavirus (HPV) infections. The papillomavirus E6 and E7 proteins are thought to function to reprogram host epithelial cells to enable viral genome replication in terminally differentiated, normally growth-arrested cells. E6 and E7 lack enzymatic activities and function by interacting and functionally altering host cell regulatory proteins. Many cellular proteins that can interact with E6 and E7 have been identified, but the biological relevance of these interactions for viral pathogenesis has not been determined. This is because papillomaviruses are species specific and do not infect heterologous hosts. Here, we use a recently established mouse papillomavirus (MmuPV1) model to investigate the role of the E7 protein in viral pathogenesis. We show that MmuPV1 E7 is necessary for papilloma formation. The retinoblastoma tumor suppressor protein (RB1) is targeted by many papillomaviral E7 proteins, including cancer-associated HPVs. We show that MmuPV1 E7 can bind RB1 and that infection with a mutant MmuPV1 virus that expresses an RB1 binding-defective E7 mutant caused smaller and fewer papillomas that arise with delayed kinetics.
Insights
Mouse papillomavirus type 1 (MmuPV1) E7 protein is essential for papilloma formation. It binds the retinoblastoma tumor suppressor protein (RB1) through a noncanonical mechanism, impacting pathogenesis independently of E2F-regulated genes.
Area of Science:
- Virology
- Oncology
- Molecular Biology
Background:
- Papillomaviruses cause epithelial hyperplasias, some progressing to squamous cell carcinomas, a significant cause of human cancers.
- Papillomavirus E6 and E7 oncoproteins reprogram host cells for viral replication but their interactions with cellular proteins are not fully understood due to species specificity.
- The mouse papillomavirus type 1 (MmuPV1) provides a model to study papillomavirus pathogenesis in vivo.
Purpose of the Study:
- To investigate the role of MmuPV1 E7 protein in viral pathogenesis.
- To determine the interaction mechanism between MmuPV1 E7 and the retinoblastoma tumor suppressor protein (RB1).
- To elucidate the functional consequences of MmuPV1 E7 binding to RB1 in papilloma development.
Main Methods:
- Proteomic experiments to identify MmuPV1 E7 interacting partners.
- Analysis of MmuPV1 E7 interaction with RB1, focusing on the C-terminal domains.
- Generation and experimental infection of mice with MmuPV1 expressing an RB1-binding defective E7 mutant.
Main Results:
- MmuPV1 E7 interacts with RB1 via its C terminus and RB1's C-terminal domain, despite lacking the canonical LXCXE motif.
- MmuPV1 E7 binding to RB1 did not significantly activate E2F-regulated genes.
- MmuPV1 E7 is essential for papilloma formation; MmuPV1 E7 mutant defective for RB1 binding resulted in delayed onset, lower incidence, and smaller papillomas.
Conclusions:
- The MmuPV1 E7 protein is crucial for papilloma development in mice.
- MmuPV1 E7 targets RB1 through a noncanonical interaction, independent of E2F regulation.
- This interaction contributes to papillomavirus-mediated pathogenesis, offering insights into HPV-associated cancers.
Related Concept Videos
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Mechanisms of Retrovirus-induced Cancers
Abnormal Proliferation
Negative Regulator Molecules
Non-LTR Retrotransposons

